IZIslam H. Zaki

Islam H. Zaki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Islam H. Zaki has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Mustafa Rifaat Bashir

    Department of Radiology Duke University Medical Center Durham North Carolina USA

    3 shared publications
  • Brandon Konkel

    From the Department of Radiology (J.A.M., Z.Z., B.K., M.A.M., W.F.W., M.R.B.), Department of Electrical and Computer Engineering (M.A.M.), Department of Computer Science (M.A.M.), Center for Advanced Magnetic Resonance Development (M.R.B.), and Division of Gastroenterology, Department of Medicine (M.R.B.), Duke University, 2301 Erwin Rd, Durham, NC 27710

    2 shared publications
  • Kyle J. Lafata

    Department of Electrical and Computer Engineering, Duke University

    2 shared publications
  • Aleksandra Radjenovic

    School of Cardiovascular & Metabolic Health, University of Glasgow, BHF Glasgow Cardiovascular Research Centre (GCRC), 126 University Place, Glasgow, G12 8TA, United Kingdom

    1 shared publication
  • Amadu Toronka

    Department of Radiology, Duke University Medical Center, Durham, USA

    1 shared publication
  • Csanad G. Varallyay

    1 shared publication

Latest Publications

  • Systematic Analysis of Common Factors Impacting Deep Learning Model Generalizability in Liver Segmentation

    by Brandon Konkel, Jacob Macdonald, Kyle Lafata, Islam H. Zaki, Erol Bozdogan, Mohammad Chaudhry, Yuqi Wang, Gemini Janas, Walter F. Wiggins, Mustafa R. Bashir

    To investigate the effect of training data type on generalizability of deep learning liver segmentation models. This Health Insurance Portability and Accountability Act–compliant retrospective study included 860 MRI and CT abdominal scans obtained between February 2013 and March 2018 and 210 volumes from public datasets. Five single-source models were trained on 100 scans each of T1-weighted fat-suppressed portal venous (dynportal), T1-weighted fat-suppressed precontrast (dynpre), proton density opposed-phase (opposed), single-shot fast spin-echo (ssfse), and T1-weighted non–fat-suppressed (t1nfs) sequence types. A sixth multisource (DeepAll) model was trained on 100 scans consisting of 20 randomly selected scans from each of the five source domains. All models were tested against 18 target domains from unseen vendors, MRI types, and modality (CT). The Dice-Sørensen coefficient (DSC) was used to quantify similarity between manual and model segmentations. Single-source model performance did not degrade significantly against unseen vendor data. Models trained on T1-weighted dynamic data generally performed well on other T1-weighted dynamic data (DSC = 0.848 ± 0.183 [SD]). The opposed model generalized moderately well to all unseen MRI types (DSC = 0.703 ± 0.229). The ssfse model failed to generalize well to any other MRI type (DSC = 0.089 ± 0.153). Dynamic and opposed models generalized moderately well to CT data (DSC = 0.744 ± 0.206), whereas other single-source models performed poorly (DSC = 0.181 ± 0.192). The DeepAll model generalized well across vendor, modality, and MRI type and against externally sourced data. Domain shift in liver segmentation appears to be tied to variations in soft-tissue contrast and can be effectively bridged with diversification of soft-tissue representation in training data. Keywords: Convolutional Neural Network (CNN), Deep Learning Algorithms, Machine Learning Algorithms, Supervised Learning, CT, MRI, Liver Segmentation Supplemental material is available for this article. © RSNA, 2023


  • CT-derived body composition measurements as predictors for neoadjuvant treatment tolerance and survival in gastroesophageal adenocarcinoma

    by Mariana R. DeFreitas, Amadu Toronka, Marybeth A. Nedrud, Sarah Cubberley, Islam H. Zaki, Brandon Konkel, Hope E. Uronis, Manisha Palta, Dan G. Blazer, Kyle J. Lafata, et al.

    Purpose Treatment for gastroesophageal adenocarcinomas can result in significant morbidity and mortality. The purpose of this study is to supplement methods for choosing treatment strategy by assessing the relationship between CT-derived body composition, patient, and tumor features, and clinical outcomes in this population. Methods Patients with neoadjuvant treatment, biopsy-proven gastroesophageal adenocarcinoma, and initial staging CTs were retrospectively identified from institutional clinic encounters between 2000 and 2019. Details about patient, disease, treatment, and outcomes (including therapy tolerance and survival) were extracted from electronic medical records. A deep learning semantic segmentation algorithm was utilized to measure cross-sectional areas of skeletal muscle (SM), visceral fat (VF), and subcutaneous fat (SF) at the L3 vertebra level on staging CTs. Univariate and multivariate analyses were performed to assess the relationships between predictors and outcomes. Results 142 patients were evaluated. Median survival was 52 months. Univariate and multivariate analysis showed significant associations between treatment tolerance and SM and VF area, SM to fat and VF to SF ratios, and skeletal muscle index (SMI) (p = 0.004–0.04). Increased survival was associated with increased body mass index (BMI) (p = 0.01) and increased SMI (p = 0.004). A multivariate Cox model consisting of BMI, SMI, age, gender, and stage demonstrated that patients in the high-risk group had significantly lower survival (HR = 1.77, 95% CI = 1.13–2.78, p = 0.008). Conclusion CT-based measures of body composition in patients with gastroesophageal adenocarcinoma may be independent predictors of treatment complications and survival and can supplement methods for assessing functional status during treatment planning. Graphical abstract


  • Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI

    by Kim-Lien Nguyen, Takegawa Yoshida, Nikhita Kathuria-Prakash, Islam H. Zaki, Csanad G. Varallyay, Scott I. Semple, Rola Saouaf, Cynthia K. Rigsby, Sokratis Stoumpos, Kevin K. Whitehead, et al.

    Multicenter off-label experience in 4240 diagnostic ferumoxytol injections for MRI at nine sites in the United States and two sites in the United Kingdom showed no serious adverse events or adverse... Background Ferumoxytol is approved for use in the treatment of iron deficiency anemia, but it can serve as an alternative to gadolinium-based contrast agents. On the basis of postmarketing surveill...